These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9054655)
1. High intensity of oral anticoagulant therapy in patients with cerebral haemorrhage: cause or consequence of the bleeding? Cannegieter SC; Rosendaal FR; Bollen EL; Briët E Br J Haematol; 1997 Mar; 96(3):497-9. PubMed ID: 9054655 [TBL] [Abstract][Full Text] [Related]
2. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. European Atrial Fibrillation Trial Study Group N Engl J Med; 1995 Jul; 333(1):5-10. PubMed ID: 7776995 [TBL] [Abstract][Full Text] [Related]
3. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. Hylek EM; Skates SJ; Sheehan MA; Singer DE N Engl J Med; 1996 Aug; 335(8):540-6. PubMed ID: 8678931 [TBL] [Abstract][Full Text] [Related]
4. Oral anticoagulation for cerebral ischemia of arterial origin: high initial bleeding risk. Torn M; Algra A; Rosendaal FR Neurology; 2001 Dec; 57(11):1993-9. PubMed ID: 11739815 [TBL] [Abstract][Full Text] [Related]
5. Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications. ten Berg JM; Hutten BA; Kelder JC; Verheugt FW; Plokker HW Circulation; 2001 Apr; 103(16):2042-7. PubMed ID: 11319192 [TBL] [Abstract][Full Text] [Related]
6. Coagulation Testing in Intracerebral Hemorrhage Related to Non-vitamin K Antagonist Oral Anticoagulants. Purrucker JC; Rizos T; Haas K; Wolf M; Khan S; Heuschmann PU; Veltkamp R; Neurocrit Care; 2017 Oct; 27(2):208-213. PubMed ID: 28477151 [TBL] [Abstract][Full Text] [Related]
15. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy. Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834 [TBL] [Abstract][Full Text] [Related]
16. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin. Yamamoto R; Nakae Y; Tanaka F; Johkura K J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270 [TBL] [Abstract][Full Text] [Related]
17. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473 [TBL] [Abstract][Full Text] [Related]
18. [Laboratory coagulation tests in patients treated by direct oral anticoagulants (DOACs)]. Sié P Presse Med; 2015; 44(7-8):772-8. PubMed ID: 26248706 [TBL] [Abstract][Full Text] [Related]
19. Questionable reversal of anticoagulation in the therapeutic management of cerebral haemorrhage associated with vitamin K antagonists. Alonso de Leciñana M; Huertas N; Egido JA; Muriel A; García A; Ruiz-Ares G; Díez-Tejedor E; Fuentes B Thromb Haemost; 2013 Dec; 110(6):1145-51. PubMed ID: 24030842 [TBL] [Abstract][Full Text] [Related]
20. Risk of stroke during long-term anticoagulant therapy in patients after myocardial infarction. Azar AJ; Koudstaal PJ; Wintzen AR; van Bergen PF; Jonker JJ; Deckers JW Ann Neurol; 1996 Mar; 39(3):301-7. PubMed ID: 8602748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]